Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
10,700
+5,300
+98% +$570K ﹤0.01% 5946
2026
Q1
$553K Buy
+5,400
New +$550K ﹤0.01% 7815
2025
Q3
Sell
-57,200
Closed -$4.36M 11462
2025
Q2
$4.36M Buy
57,200
+50,500
+754% +$3.7M ﹤0.01% 3184
2025
Q1
$475K Sell
6,700
-26,900
-80% -$2.1M ﹤0.01% 6963
2024
Q4
$2.63M Sell
33,600
-96,200
-74% -$8.98M ﹤0.01% 3655
2024
Q3
$13.3M Buy
129,800
+99,900
+334% +$8.29M ﹤0.01% 1632
2024
Q2
$2.27M Sell
29,900
-300
-1% -$21.3K ﹤0.01% 4268
2024
Q1
$2.27M Sell
30,200
-26,300
-47% -$2.09M ﹤0.01% 3904
2023
Q4
$4.16M Buy
+56,500
New +$3.5M ﹤0.01% 3127

Other funds holding NUVL

Jane Street's NUVL Position: Q2 2026 in Review

Jane Street reduced its Nuvalent (NUVL) stake by 91% in Q2 2026, selling an estimated $7.57M and leaving 6,798 shares worth $840K. The position accounts for ﹤0.01% of the portfolio, ranked #6905.

Jane Street first reported a position in NUVL in Q2 2022 and has held it in 10 quarters since. The position peaked at $7.9M in Q1 2026. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Jane Street held 6,798 shares of Nuvalent worth $840K as of Q2 2026.
  • Jane Street sold 70,340 Nuvalent shares in Q2 2026, an estimated $7.57M.
  • Nuvalent made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6905 holding.
  • Jane Street first reported a position in Nuvalent in Q2 2022 and has held it in 10 quarters since.
  • Jane Street's Nuvalent position peaked at $7.9M in Q1 2026.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.